A Study in Healthy Men to Find Out How Different Doses of BI 3009947 Are Tolerated and How Different Formulations or Food Influence How BI 3009947 is Taken up Into the Blood
Clinical trial NCT07250048 · TERMINATED
Trial details
- NCT number
- NCT07250048
- Sponsor
- Boehringer Ingelheim
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-21
- Primary completion
- 2026-03-02
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.